Chang Gung Memorial Hospital, Linkou
Taoyuan District, Taiwan
15 recruiting
Showing 1–15 of 15 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3
Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically Removed, Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
Non-small Cell Lung Cancer
Boehringer Ingelheim400 enrolled192 locationsNCT07195695
Recruiting
Phase 3
Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
Lung Cancer, Non-squamous, Non-small Cell
Boehringer Ingelheim416 enrolled162 locationsNCT06151574
Recruiting
Phase 3
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Boehringer Ingelheim6,000 enrolled652 locationsNCT06424288
Recruiting
Phase 3
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Gilead Sciences695 enrolled204 locationsNCT06801834
Recruiting
Phase 3
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Sjögren's Syndrome
Amgen844 enrolled144 locationsNCT06747949
Recruiting
Phase 2
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
Neuroendocrine NeoplasmsSmall Cell Lung CarcinomaExtra-pulmonary Neuroendocrine Carcinoma
Boehringer Ingelheim174 enrolled59 locationsNCT05882058
Recruiting
Phase 1
A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study
Colon Cancer Stage I
Medigen Biotechnology Corporation18 enrolled1 locationNCT05394714
Recruiting
Phase 2
Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)
Relapsed or Refractory Peripheral T-cell Lymphoma
Great Novel Therapeutics Biotech & Medicals Corporation33 enrolled5 locationsNCT05833724
Recruiting
Phase 2
Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
Hepatocellular Carcinoma
Lukas Biomedical Inc.95 enrolled13 locationsNCT05304481
Recruiting
Not Applicable
Developing and Testing the Effect of Online Interactive Videos in Improving Low Anterior Resection Syndrome.
Rectal Cancer
Chang Gung Memorial Hospital110 enrolled1 locationNCT06628674
Recruiting
Phase 3
Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals
HIV-1-infectionNon-Adherence, Medication
Chang Gung Memorial Hospital40 enrolled4 locationsNCT06507059
Recruiting
Phase 2
Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells
Chronic Obstructive Pulmonary Disease
Meribank Biotech Co., Ltd.90 enrolled2 locationsNCT06491043
Recruiting
Phase 1Phase 2
Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC Patients
Advanced Solid TumorNon-small Cell Lung CancerHER2 Mutations
Anbogen Therapeutics, Inc.61 enrolled5 locationsNCT05532696
Recruiting
Not Applicable
Comparing Bp-MRI and Mp-MRI for Prostate Cancer Screening Accuracy
Prostate CancerMagnetic Resonance ImagingRandomized Controlled Trial
Chang Gung Memorial Hospital370 enrolled1 locationNCT06402552